Mome Device
Payments companies reported to CMS as associated with Mome Device. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mome Device, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mome Device
These are the largest totals companies reported as associated with Mome Device. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Matthew Goldstein | Paoli, PA | Clinical Cardiac Electrophysiology | $7,262.50 |
| Philip Nimoityn | Philadelphia, PA | Cardiovascular Disease | $5,425.00 |
| Jeffrey Feiner | Laguna Hills, CA | Cardiovascular Disease | $4,140.50 |
| Matthew Hillis | Broomall, PA | Clinical Cardiac Electrophysiology | $3,850.00 |
| Colin Movsowitz | Paoli, PA | Clinical Cardiac Electrophysiology | $2,712.50 |
| Jeremy Ruskin | Boston, MA | Clinical Cardiac Electrophysiology | $2,187.50 |
| Evan May | El Paso, TX | Cardiovascular Disease | $2,100.00 |
| Jeffrey Hawkins | San Diego, CA | Family | $410.44 |
| Jay Tiongson | Mission Viejo, CA | Clinical Cardiac Electrophysiology | $283.88 |
| Mohammad Pashmforoush | Oceanside, CA | Cardiovascular Disease | $226.51 |
Prescribed Mome Device?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.